TCGX
Venture Capital
Science-driven investment firm dedicated to advancing disruptive medicines in biotech.
Seed
Early Stage
Late Stage
Biotech
Healthcare
- Headquarters
- Palo Alto, United States
- Founded
- 2021
- Website
- tcgcrossover.com
- AUM
- $3
- Last Investment
- Oct 2025
- Geographic Focus
- United States, Europe, China
Investment Thesis
Invests in visionary entrepreneurs leveraging scientific breakthroughs to develop transformative medicines improving human health.
Investment History
Sign up to view investment history
Create a free account to see deal history, investment amounts, and round details.
Create Free Account